Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 27, 2011

Primary Completion Date

September 10, 2014

Study Completion Date

January 22, 2018

Conditions
HIV
Interventions
DRUG

Atazanavir Sulphate

DRUG

Ritonavir

Trial Locations (32)

1141

Local Institution, Buenos Aires, Bs As

1425

Local Institution, Bunos Aires

1501

Local Institution, Benoni

2001

Local Institution, Soweto

2092

Local Institution, Coronationville

6001

Local Institution, Port Elizabeth

6014

Local Institution, Port Elizabeth

7505

Local Institution, Parrow Valley

9301

Local Institution, Bloemfontein

13210

SUNY Upstate Medical University, Syracuse

20010

Children'S National Medical Center, Washington D.C.

28041

Local Institution, Madrid

44160

Local Institution, Guadalajara

44280

Local Institution, Guadalajara

71256

Local Institution, Oaxaca City

72000

Local Institution, Puebla City

72205

Local Institution, Bucharest

97000

Local Institution, Mérida

189635

Local Institution, Saint Petersburg

198103

Local Institution, Saint Petersburg

214006

Local Institution, Smolensk

8380418

Local Institution, Santiago

50070-500

Local Institution, Recife

90020-090

Local Institution, Porto Alegre

90035-903

Local Institution, Porto Alegre

14049-900

Local Institution, Ribeirão Preto

Unknown

Local Institution, Santiago

06720

Local Institution, Df

01-201

Local Institution, Warsaw

0001

Local Institution, Pretoria

08950

Local Institution, Barcelona

B9 5ST

Local Institution, Birmingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY